Member Info for Chris0123

"Whack-a-Mole" Aldebaran/AmateurHaematologist - isn't that what happened to you on the sensible share forum

Get over yourself Aldebaran, so needy!

No, I think they were great. Anyway, humour isn't a prominent trait of a narcissist, so don't buy tickets to my next comedy gig!

Notposting - simple, if you "keep encountering stupidity" - reduce the number of mirrors in your bedsit! Hope that helps.

Who's got the Conch?

Thanks for that inciteful intervention Snooker. We'll bid you good day then, so you can spend the rest of the day playing with your balls.

Oh great one! I read this post in exaltation - NOT ! You really do come across somewhat deranged and power crazy. Now stop stroking your own ego and go and feed the white cat.

You hitched up that wagon yet?

Notposting making Alderbaran come across as a plausible hemo investor these days. We know he is not it's that old good cop bad cop trick. The two of them droning on incessantly. We don't want or need self centred self appointed moderators. So tackle your horses get in your wagons and ride on into the next town to ply your worthless medicines.

Notposting using a Cyrox over reaction to flatter and deceive him and using that to throw barbed nonsense at Pingu. Taking desperation to a new level.

RSU's may be more telling than they are being given in relation to air time here today. Why give them now?

Yes, reward staff for their efforts, yes they do that but cash or stock is given wnen restrictive conditions are met. Either stock is then awarded or the cash equivalent. You don't incentivize people with unachievable goals, so those taking them, and agreeing to them, must believe goals are attainable.

Another reason for RSU's is to reward staff and preserve cash in short term - that's no bad thing.

The milestones may be Estonia specific to get cash generative as soon as possible.

However, RSU's if deals are afoot or being considered (depending how far down the road they are) RSU's might often be agreed with a potential acquirer as they involve new equity, albeit in this case not huge in the grand scheme of a deal.

Another reason for issuing RSU's is that they may be considered as a valuable retention tool for any acquirer. In fact, the acquirer may agree or even initiate a new equity plan as a tool to to ensure they retain key employees of the target company. In this case Hemogenyx. This is more likely if the acquirer want to keep specific talent after the deal closes.

Pure speculation but these are genuine reasons why RSU's can be issued. But re-read the plaudits he gives his staff at the end of the RSU section of the RNS - soulds more like a leaving do / handover statement. Now that is perhaps streching even my imagination.

Finally to Aldebaran, stop being such a d*ck.

Nag! Nag! Nag!

You've made your point time and time again. Do something constructive like contact him if it bothers you that much ...instead of droaning on incessantly.

With "good" results from 3 patients, CEO's words in last interview not mine. No measure of cancer cells in P3, Estonia giving financial options .

The DSMB would have to find something noone else has to knock paediatrics and Cohort 2 in adults back. VS stated we "will" submit data for the DSMB - do you think the MD Anderson are going to submit rubbish. They know their onions.

A sweat for those out and not buying before Monday - bot for those paid up and still in.

That clears that up . Was aware of it a month and forgot about that one did an AI search and that conference certainly didn't come up. AI search not so great on that one. Thanks for clarification.

Hulver - do you know which conference VS is attending? The only one I can find in Boston happening on 26th - 29th Oct is the Asscociation of Financial Professionals Annual Conference" - the dates would fit but unsure of the subject-matter. It is for Treasury & Financial Professionals to network and share insights on topics like AI, digital payments and risk-management. Subject to your source - does this mean there is money coming in to manage. "Digital payments" from Estonia perhaps. As I say, nothing confirmed just a lead from Hulver and probably wild hunches if this were the conference.

Don't be such a clown Alveharen (excuse the spelling !!!). The DSMB have a role to play and a duty to PATIENTS (note spelling) and to do that responsibly.

OR, would you rather there wasn't proper due diligence that looked after the safety of PATIENTS and in particular the safety of the next cohort of severely sick people including children.

Have a little PATIENCE will you.

All Hemo's are a good read and I am happy reading your contributions.

I can see why you have all come out today. Not to justify yourselves I hope just to set the record straight on a few suppositions.

That said it reminded me of Life of Brian. You know the scene, just replace I'm Spartacus either I'm Hemo... have a good weekend.

I don't know about institutional investors in Hemo but there's plenty of evidence today of institutionalised investors. Who the eff didn't lock the main gate!

Scientific Research Director (SRD): Good morning, how many interviews have we got lined up for that scientist post this morning

HR: Just the two Haywain Knowshissh*t (unusual name) & Aldebaran Inavacta (AI for short)

SRD: What times are they?

HR: HK is this morning but AI early evening 7.30 PM

SRD: Why the heaven 7.30PM?

HR: He has to have a nap - works through the night.

SRD: CV's I have read, but HK's is 10 pages displaying significant credentials butonly have a 1 page one from AI - ChatGPT generated it seems.

Much later:-

HR: Well, how did the interviews go?

SRD: half hour with HK and 5 hours with AI. AI asked me if I was qualified for my role, made me question my life's work.

HR: You'll have to select one, we have some very important life saving breakthroughs to achieve.

SRD: That's easy - Haywain knows his sh*t and Aldebaran is full of sh*t.

HR: Well HK has been a scientist for 20 years plus and AI has ZERO years in the field.

SRD: Yeah, in whom would you trust?

Vander - yes, an easy flow of money may well move things along somewhat but ultimately every element of the science and every sapect of patient health combined with statutory reviews AND COMPLIANCE need to be satified. Powering ahead, even with plenty of money just aint that easy.